NuvOx Therapeutics Email Format

Pharmaceutical ManufacturingArizona, United States11-50 Employees

NuvOx Therapeutics is a Tucson-based biotechnology company developing a first-in-class oxygen therapeutic intended to treat life-threatening diseases in which tissue hypoxia plays a role. Preclinical work has shown therapeutic effects in more than 30 animal studies across seven indications. In early clinical development, Phase Ib/II trials in stroke and oncology have demonstrated safety and signals of efficacy, and the company is planning a Phase IIa trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure. Situated in the pharmaceutical manufacturing sector, NuvOx has established a GMP production facility in Tucson to manufacture its injectable pharmaceuticals. Its potential customers include clinicians and patients affected by hypoxia-related conditions such as stroke, cancer, and respiratory failure due to COVID-19, where the therapy could address unmet needs. The company is a small biotechnology organization that is advancing its clinical program from its base in Tucson, Arizona, while expanding its manufacturing capabilities to support later-stage development.

Sign up for free to view info

Company overview Employee directory